Jubilant Life Sciences announces a price increase of up to 15 per cent for its Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) with an immediate effect, for non-contract customers as well as wherever existing contracts permit.
Jubilant Life Sciences, a global leader in the pyridine, picolines as well as nutrition industry, is an integrated global pharmaceutical and also a life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The company’s Pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products as well as Contract Manufacturing of Sterile and Non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.
Post the regulatory filing of this update by the company on the stock exchanges, Jubilant share price saw a drop of almost 2.86 per cent or 17.75 points. It is currently trading at Rs 602.85 apiece on NSE at 2.35 PM. The intraday high of the share so far was reported at Rs 626.55 and the intraday low is Rs 598.00.
Jubilant share price opened at Rs 622.50, about 2 points higher than its previous closing of Rs 620.60.
A total of 3,94,099 shares of the company have exchanged hands on the counter of NSE aggregating to a total value of Rs 2,406.60. The 20 days average trading volume of the share is 5,30,951.
As of today, Jubilant has a market cap of Rs 9884.99 crores. The Promoter holding pledged by the company is as low as 5.67. The share touched a 52 week high as well as a life time high of 727.00 on 1st December 2016. The life time low is Rs 3.46 made on 16th April 2001 and the 52 week high is Rs 275.65 touched on 18th January 2016.
Jubilant is one of the multibagger stocks recommended by Dynamic levels. Get the historical share price performance of the scrip at Jubilant share price history.
No comments:
Post a Comment